XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of reportable segments (Details) - AUD ($)
6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Revenue from contracts with customers $ 4,153,947 $ 2,051,016
Other income 823,922 1,403,956
Finance income 79,747 15,040
Total segment revenue & other income 5,057,616 3,470,012
Depreciation and amortisation (330,187) (281,304)
Finance costs (15,872) (4,243)
Raw materials and change in inventories (2,147,685) (1,128,879)
Commissions (113,415) (60,961)
Employee benefits expenses (3,109,064) (2,975,262)
Advertising and promotional expenses (1,537,769) (840,673)
Professional fees (790,612) (730,419)
Research and development expenses (558,306) (370,961)
Impairment reversal/(expenses) (280,725) 302
Other expenses (1,782,292) (958,983)
Total segment expenses (10,665,927) (7,351,383)
Income tax expenses 148,013
Loss for the period (5,460,298) (3,881,371)
EasyDNA [Member]    
IfrsStatementLineItems [Line Items]    
Revenue from contracts with customers 3,813,482 2,044,152
Other income
Finance income
Total segment revenue & other income 3,813,482 2,044,152
Depreciation and amortisation (15,211) (5,637)
Finance costs (1,317) (723)
Raw materials and change in inventories (1,965,338) (1,106,624)
Commissions (97,918) (60,961)
Employee benefits expenses (777,593) (579,391)
Advertising and promotional expenses (946,757) (386,794)
Professional fees (1,710) (20,346)
Research and development expenses
Impairment reversal/(expenses)
Other expenses (462,753) (254,775)
Total segment expenses (4,268,597) (2,415,251)
Income tax expenses
Loss for the period (455,115) (371,099)
Affinity DNA [Member]    
IfrsStatementLineItems [Line Items]    
Revenue from contracts with customers 330,777
Other income
Finance income
Total segment revenue & other income 330,777
Depreciation and amortisation (10,521)
Finance costs (1,432)
Raw materials and change in inventories (155,686)
Commissions (15,497)
Employee benefits expenses (64,277)
Advertising and promotional expenses (13,572)
Professional fees
Research and development expenses
Impairment reversal/(expenses)
Other expenses (56,973)
Total segment expenses (317,958)
Income tax expenses
Loss for the period 12,819
GeneType/Corporate [Member]    
IfrsStatementLineItems [Line Items]    
Revenue from contracts with customers 9,688 6,864
Other income 823,922 1,403,956
Finance income 79,747 15,040
Total segment revenue & other income 913,357 1,425,860
Depreciation and amortisation (304,455) (275,667)
Finance costs (13,123) (3,520)
Raw materials and change in inventories (26,661) (22,255)
Commissions
Employee benefits expenses (2,267,194) (2,395,871)
Advertising and promotional expenses (577,440) (453,879)
Professional fees (788,902) (710,073)
Research and development expenses (558,306) (370,961)
Impairment reversal/(expenses) (280,725) 302
Other expenses (1,262,566) (704,208)
Total segment expenses (6,079,372) (4,936,132)
Income tax expenses 148,013
Loss for the period $ (5,018,002) $ (3,510,272)